Glucotrack, Inc. announced that Luis Malavé has been elected as Chairman of its Board of Directors, effective immediately. Mr. Malavé brings more than 30 years of leadership experience in the MedTech industry, primarily in diabetes management, spanning all company stages from private startups to large-cap publicly listed companies. He has extensive expertise in product development, operations, marketing, strategic partnerships, and US FDA regulatory strategy.

Mr. Malavé currently serves as President of EOFLOW CO. Ltd., a company listed on the Korea Stock Exchange that has developed a wearable disposable insulin pump. Prior to that, Mr. Malavé was the President and CEO of Palyon Medical, maker of an implantable drug-delivery system that spun out from German medical-technology giant Fresenius SE.

Prior to Palyon, he spent nearly a decade at insulin pump maker Insulet Corp., joining as its Senior Vice President of Research, Development and Engineering in the first year and as Chief Operating Officer as Insulet grew to a multi-billion dollar public company. He also held various senior management positions at MiniMed, fueling its growth innovation and growth to eventual acquisition by Medtronic. Mr. Malavé earned his Bachelor?s degree in Mathematics and Computer Science from the University of Minnesota, a Master?s degree in Software Engineering from the University of St.

Thomas, and an MBA from the University of Maryland.